Participants 82 109 5
patients with schizophrenia
Participants 403 622 7
Forty-seven patients with schizophrenia meeting criteria for deficit syndrome were randomized to D-cycloserine, 50 mg/d (n=23) or placebo (n=24) added to their conventional neuroleptic for an 8-week, double-blind trial.
Participants 902 950 4
Thirty-nine patients completed the 8-week trial.
